참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Phenyl chloroformate | HCID 15891 | — |
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | 4-Methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-yl-amine | HCID 22015735 | — |
| 반응물 | (4-Methoxy-7-phenyl-benzothiazol-2-yl)-carbamic acid benzyl ester | HCID 86584926 | — |
| 반응물 | HCID 178521615 | HCID 178521615 | — |
| 용매 | Dimethyl Sulfoxide | HCID 679 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | HCID 178488703 | HCID 178488703 | 7% |
반응 단계
4-Methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-ylamine (69 mg, 0.26 mmol) is first reacted with phenyl chloroformate as described for (4-methoxy-7-phenyl-benzothiazol-2-yl)-carbamic acid benzyl ester in WO01/97786 and then with N-ethyl-diisopropylamine (0.090 ml, 0.52 mmol) and (trans)-cyclohexane-1,4-diol (60 mg, 0.52 mmol) in dimethyl sulfoxide (10 ml) at 50° C. for 2 h. Then 100 ml dichoromethane are added, the mixture is extracted with saturated aqueous sodium carbonate and the organic phase is dried and evaporated. Flash-chromatographic purification (silica, eluting with dichloromethane/methanol) yielded the title compound as white solid (7% yield). MS: m/e=407(M+H+), mp 282-284° C. Following the general method of example 1 the compounds of examples 2 to 11 were prepared.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07304058B2 |
|---|
| 출처 데이터셋 | uspto-grants-2007_12 |
|---|
| ORD ID | ord-11fd3b0b8d58482a8356e58c8abe301d |
|---|
| 출처 메모 | uspto-grants-2007_12 |
|---|